MedPath

Assessing Patient-Reported Experience of Care for Home Dialysis (ASPIRED)

Completed
Conditions
Home Dialysis
End Stage Renal Disease
Registration Number
NCT04435873
Lead Sponsor
Satellite Healthcare
Brief Summary

Home dialysis modalities, including peritoneal dialysis (PD) and home hemodialysis (HHD), represent alternatives to conventional in-center hemodialysis (HD) that for some patients may be better aligned with preferences regarding the integration of dialysis treatments into their lives. Assessment of patient experience and satisfaction with care among individuals undergoing maintenance dialysis in the United States is a national health care priority and mandated by Congress. While validated instruments (ICH CAHPS) are in use to assess patient experience with in-center HD, currently no validated instruments are available to measure patient-reported experience in home dialysis.

This Home Patient Experience Survey Validation Study is an in-house research study conducted in partnership with the University of Washington.

Detailed Description

Assessment of patient experience and satisfaction with care among individuals undergoing maintenance dialysis in the United States is a national health care priority and mandated by Congress. No validated instruments are available to measure the patient-reported experience of care in-home dialysis patients. Such tools are needed as more patients are expected to choose home dialysis therapies in the future. This study aims to validate a home patient experience survey instrument.

This is a cross-sectional validation to determine the measurement properties of a new home dialysis patient experience survey instrument. Satellite Healthcare home dialysis patients will be approached by mail or by phone to complete the survey.

The aim of this study is to perform field testing for this newly developed instrument for the purposes of instrument validation and to determine survey instrument measurement properties. This will include the evaluation of any multi-item scales as well as an overall score.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
513
Inclusion Criteria
  • Patients receiving care for home dialysis at a facility that provides care for >= 3 patients at the time of cohort identification.
Exclusion Criteria
  • Age < 18 years
  • Patients receiving care for home dialysis at the facility for less than 3 months
  • Institutionalized (senior nursing facility/multi-resident facility) or Hospice care patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the measurement modelthrough survey completion, an average of 6 months

The evaluation will encompass the survey burden, presence of a floor or ceiling effect for any item, test-retest reliability, development of multi-item subscales, internal consistency and reliability, center level reliability of the items and composites, and construct validity.

Secondary Outcome Measures
NameTimeMethod
Survey response ratethrough survey completion, an average of 6 months

Percent (%) of participants contacted who complete survey instrument

Trial Locations

Locations (32)

Satellite WellBound of Daly City

🇺🇸

Daly City, California, United States

Satellite Wellbound of Emeryville

🇺🇸

Emeryville, California, United States

Satellite Dialysis Folsom

🇺🇸

Folsom, California, United States

Satellite Wellbound of Fremont

🇺🇸

Fremont, California, United States

Satellite Healthcare Gilroy

🇺🇸

Gilroy, California, United States

Satellite Healthcare Larkspur

🇺🇸

Greenbrae, California, United States

Satellite Healthcare Laguna Hills

🇺🇸

Laguna Hills, California, United States

Satellite Healthcare Merced

🇺🇸

Merced, California, United States

Satellite WellBound of Milpitas

🇺🇸

Milpitas, California, United States

Satellite WellBound of Modesto

🇺🇸

Modesto, California, United States

Scroll for more (22 remaining)
Satellite WellBound of Daly City
🇺🇸Daly City, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.